UEG Week Recordings UEG Week Posters Online courses Guidelines Mistakes in... Podcasts Webinars
new
Gut Guide online
Visit ueg.eu Create myUEG account Log In
Visit ueg.eu Create myUEG account Log In

Filters:

UEG Presentation
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky
UEG Research Prize 2024: The WATERLAND study

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

UEG Research Prize 2024: The WATERLAND study

Silvio Danese 1, Enrique de-Madaria 2

Affiliations

1 Vita-Salute San Raffaele University - IRCCS San Raffaele Scientific Institute, Milan, Italy

2 Hospital General Universitario de Alicante - Gastroenterology, Hospital General Universitario de Ali, Alicante, Spain

Summary

AI Generated

The speaker presented the Waterfall and Waterland trials investigating fluid resuscitation strategies in acute pancreatitis, reporting that the Waterfall trial was stopped early when aggressive fluid resuscitation showed increased fluid overload risk without improved outcomes.

  • The Waterfall trial, an international randomised trial across 18 centres in 4 countries, was stopped at interim analysis for safety reasons after aggressive fluid resuscitation was associated with increased fluid overload and no improvement in outcomes compared to moderate resuscitation, as stated by the speaker.
  • The speaker reported that the American College of Gastroenterology guidelines now recommend moderately aggressive fluid resuscitation in acute pancreatitis based on the Waterfall trial findings.
  • An earlier 40-patient trial comparing lactated Ringer's to normal saline showed lower C-reactive protein levels at 2-3 days with lactated Ringer's, though guidelines noted this was not a hard patient outcome.
  • The ongoing Waterland trial is randomising almost 800 patients across 47 centres in 18 countries to lactated Ringer's versus normal saline for at least 48 hours, with severity as the primary outcome; the speaker stated results are pending and this will be the largest acute pancreatitis trial by patient and country count.
  • The speaker disclosed receiving the UEG Research Prize 2021 and previous UEG Rising Star and Ambassador Awards for this fluid resuscitation research program spanning approximately 15 years.
Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Event

UEG Week Vienna 2024

Session

Opening Plenary

Citation

United European Gastroenterology Journal 2024; 12 (Supplement 8)

Published

2024

More Like This:

Mistakes in Pancreatic exocrine insufficiency and how to avoid them

Mistakes in Pancreatic exocrine insufficiency and how to avoid them

Matthias Löhr Matthias Löhr, J. Enrique Domínguez Muñoz, Miroslav Vujasinovic

Malignancy in IBD with Hannah Gordon

Malignancy in IBD with Hannah Gordon

Pradeep Mundre Pradeep Mundre, Hannah Gordon

Mistakes in the management of peritoneal malignancies and how to avoid them

Mistakes in the management of peritoneal malignancies and how to avoid them

Charlotte Rabl Charlotte Rabl, Tarkan Jäger, Andrea Barberis, Matteo Santoliquido, Francesco Saverio Papadia

Transitional care with Patrizia Burra & Jorge Amil Dias

Transitional care with Patrizia Burra & Jorge Amil Dias

Pradeep Mundre Pradeep Mundre, Jorge Amil Dias, Patrizia Burra

Pancreatic cystic neoplasms with Marco del Chiaro

Pancreatic cystic neoplasms with Marco del Chiaro

Egle Dieninyte - Misiune Egle Dieninyte - Misiune, Marco Del Chiaro

Mistakes in biomarkers for IBD and how to avoid them

Mistakes in biomarkers for IBD and how to avoid them

James C. Lee James C. Lee, Chris Palmer-Jones

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in Pancreatic exocrine insufficiency and how to avoid them

Miroslav Vujasinovic, J. Enrique Domínguez Muñoz, Matthias Löhr

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Pancreatic exocrine insufficiency (PEI) is a common yet frequently under-recognised cause of maldigestion, malabsorption, and malnutrition. Although traditionally associated with primary pancreatic disorders such as chronic pancreatitis, cystic fibrosis, pancreatic cancer, or pancreatic surgery, it is now evident that PEI also occurs in a wide range of extra-pancreatic conditions and clinical settings. Advances in diagnostic testing and expanding clinical awareness have improved detection; however, significant misconceptions persist regarding when to suspect PEI; how to interpret diagnostic tests; and how to initiate, optimise, and monitor pancreatic enzyme replacement therapy (PERT). In everyday practice, these errors may lead to delayed diagnosis, inappropriate treatment, persistent symptoms, and preventable nutritional deficiencies. This “Mistakes in…” article highlights common pitfalls in the diagnosis and management of PEI, focusing on inappropriate reliance on faecal elastase testing, failure to recognise secondary causes, undertreatment with PERT, and inadequate nutritional assessment. By addressing these frequent mistakes, we aim to promote a more structured, patient-centred, and evidence-informed approach to PEI that improves clinical outcomes and quality of life.

Topics

Pancreas

Published

2026

More Like This:

Mistakes in Pancreatic exocrine insufficiency and how to avoid them

Mistakes in Pancreatic exocrine insufficiency and how to avoid them

Matthias Löhr Matthias Löhr, J. Enrique Domínguez Muñoz, Miroslav Vujasinovic

Malignancy in IBD with Hannah Gordon

Malignancy in IBD with Hannah Gordon

Pradeep Mundre Pradeep Mundre, Hannah Gordon

Mistakes in the management of peritoneal malignancies and how to avoid them

Mistakes in the management of peritoneal malignancies and how to avoid them

Charlotte Rabl Charlotte Rabl, Tarkan Jäger, Andrea Barberis, Matteo Santoliquido, Francesco Saverio Papadia

Transitional care with Patrizia Burra & Jorge Amil Dias

Transitional care with Patrizia Burra & Jorge Amil Dias

Pradeep Mundre Pradeep Mundre, Jorge Amil Dias, Patrizia Burra

Pancreatic cystic neoplasms with Marco del Chiaro

Pancreatic cystic neoplasms with Marco del Chiaro

Egle Dieninyte - Misiune Egle Dieninyte - Misiune, Marco Del Chiaro

Mistakes in biomarkers for IBD and how to avoid them

Mistakes in biomarkers for IBD and how to avoid them

James C. Lee James C. Lee, Chris Palmer-Jones

UEG Podcast Episode
UEG Podcast
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Malignancy in IBD with Hannah Gordon

Hannah Gordon, Pradeep Mundre

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Topics

Digestive Oncology IBD

Published

2026

More Like This:

Mistakes in Pancreatic exocrine insufficiency and how to avoid them

Mistakes in Pancreatic exocrine insufficiency and how to avoid them

Matthias Löhr Matthias Löhr, J. Enrique Domínguez Muñoz, Miroslav Vujasinovic

Malignancy in IBD with Hannah Gordon

Malignancy in IBD with Hannah Gordon

Pradeep Mundre Pradeep Mundre, Hannah Gordon

Mistakes in the management of peritoneal malignancies and how to avoid them

Mistakes in the management of peritoneal malignancies and how to avoid them

Charlotte Rabl Charlotte Rabl, Tarkan Jäger, Andrea Barberis, Matteo Santoliquido, Francesco Saverio Papadia

Transitional care with Patrizia Burra & Jorge Amil Dias

Transitional care with Patrizia Burra & Jorge Amil Dias

Pradeep Mundre Pradeep Mundre, Jorge Amil Dias, Patrizia Burra

Pancreatic cystic neoplasms with Marco del Chiaro

Pancreatic cystic neoplasms with Marco del Chiaro

Egle Dieninyte - Misiune Egle Dieninyte - Misiune, Marco Del Chiaro

Mistakes in biomarkers for IBD and how to avoid them

Mistakes in biomarkers for IBD and how to avoid them

James C. Lee James C. Lee, Chris Palmer-Jones

UEG Mistakes In Articles
New
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in the management of peritoneal malignancies and how to avoid them

Francesco Saverio Papadia, Matteo Santoliquido, Andrea Barberis, Tarkan Jäger, Charlotte Rabl

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Peritoneal malignancies represent a complex and often misjudged clinical challenge. Historically synonymous with a terminal diagnosis, the advent of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) radically altered the prognosis for selected patients. However, progress has been jeopardised by a series of recurring and preventable errors in diagnosis, staging, and treatment selection. This article delineates the ten most critical pitfalls in managing peritoneal surface malignancies. For each pitfall, we provide evidence-based explanations, concrete clinical examples, and strategic recommendations for avoidance. We emphasise the pivotal role of early multidisciplinary discussion, precise imaging, and timely referral to high-volume expert centres to optimise patient outcomes and offer curative intent where previously there was none.

Topics

Digestive Oncology Surgery

Published

2026

More Like This:

Mistakes in Pancreatic exocrine insufficiency and how to avoid them

Mistakes in Pancreatic exocrine insufficiency and how to avoid them

Matthias Löhr Matthias Löhr, J. Enrique Domínguez Muñoz, Miroslav Vujasinovic

Malignancy in IBD with Hannah Gordon

Malignancy in IBD with Hannah Gordon

Pradeep Mundre Pradeep Mundre, Hannah Gordon

Mistakes in the management of peritoneal malignancies and how to avoid them

Mistakes in the management of peritoneal malignancies and how to avoid them

Charlotte Rabl Charlotte Rabl, Tarkan Jäger, Andrea Barberis, Matteo Santoliquido, Francesco Saverio Papadia

Transitional care with Patrizia Burra & Jorge Amil Dias

Transitional care with Patrizia Burra & Jorge Amil Dias

Pradeep Mundre Pradeep Mundre, Jorge Amil Dias, Patrizia Burra

Pancreatic cystic neoplasms with Marco del Chiaro

Pancreatic cystic neoplasms with Marco del Chiaro

Egle Dieninyte - Misiune Egle Dieninyte - Misiune, Marco Del Chiaro

Mistakes in biomarkers for IBD and how to avoid them

Mistakes in biomarkers for IBD and how to avoid them

James C. Lee James C. Lee, Chris Palmer-Jones

UEG Podcast Episode
UEG Podcast
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Transitional care with Patrizia Burra & Jorge Amil Dias

Patrizia Burra, Jorge Amil Dias, Pradeep Mundre

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Topics

Paediatrics

Published

2025

More Like This:

Mistakes in Pancreatic exocrine insufficiency and how to avoid them

Mistakes in Pancreatic exocrine insufficiency and how to avoid them

Matthias Löhr Matthias Löhr, J. Enrique Domínguez Muñoz, Miroslav Vujasinovic

Malignancy in IBD with Hannah Gordon

Malignancy in IBD with Hannah Gordon

Pradeep Mundre Pradeep Mundre, Hannah Gordon

Mistakes in the management of peritoneal malignancies and how to avoid them

Mistakes in the management of peritoneal malignancies and how to avoid them

Charlotte Rabl Charlotte Rabl, Tarkan Jäger, Andrea Barberis, Matteo Santoliquido, Francesco Saverio Papadia

Transitional care with Patrizia Burra & Jorge Amil Dias

Transitional care with Patrizia Burra & Jorge Amil Dias

Pradeep Mundre Pradeep Mundre, Jorge Amil Dias, Patrizia Burra

Pancreatic cystic neoplasms with Marco del Chiaro

Pancreatic cystic neoplasms with Marco del Chiaro

Egle Dieninyte - Misiune Egle Dieninyte - Misiune, Marco Del Chiaro

Mistakes in biomarkers for IBD and how to avoid them

Mistakes in biomarkers for IBD and how to avoid them

James C. Lee James C. Lee, Chris Palmer-Jones

UEG Podcast Episode
UEG Podcast
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Pancreatic cystic neoplasms with Marco del Chiaro

Marco Del Chiaro, Egle Dieninyte - Misiune

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

Topics

Pancreas

Published

2025

More Like This:

Mistakes in Pancreatic exocrine insufficiency and how to avoid them

Mistakes in Pancreatic exocrine insufficiency and how to avoid them

Matthias Löhr Matthias Löhr, J. Enrique Domínguez Muñoz, Miroslav Vujasinovic

Malignancy in IBD with Hannah Gordon

Malignancy in IBD with Hannah Gordon

Pradeep Mundre Pradeep Mundre, Hannah Gordon

Mistakes in the management of peritoneal malignancies and how to avoid them

Mistakes in the management of peritoneal malignancies and how to avoid them

Charlotte Rabl Charlotte Rabl, Tarkan Jäger, Andrea Barberis, Matteo Santoliquido, Francesco Saverio Papadia

Transitional care with Patrizia Burra & Jorge Amil Dias

Transitional care with Patrizia Burra & Jorge Amil Dias

Pradeep Mundre Pradeep Mundre, Jorge Amil Dias, Patrizia Burra

Pancreatic cystic neoplasms with Marco del Chiaro

Pancreatic cystic neoplasms with Marco del Chiaro

Egle Dieninyte - Misiune Egle Dieninyte - Misiune, Marco Del Chiaro

Mistakes in biomarkers for IBD and how to avoid them

Mistakes in biomarkers for IBD and how to avoid them

James C. Lee James C. Lee, Chris Palmer-Jones

UEG Mistakes In Articles
Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Log in to continue.

This content is part of Gutflix. Log in with your myUEG account, or create one free, to watch it.

Log In Create a free account

Not sure what you can access? Learn more about account types.

Mistakes in biomarkers for IBD and how to avoid them

James C. Lee, Chris Palmer-Jones

Summary

AI Generated

Summary is not available for this content yet.

Download PDF

Was this helpful?

Thanks for your feedback.

This summary was generated by an AI large language model based on the content transcript. It is for informational purposes only and should not be considered a substitute for clinical judgment. Always rely on your professional expertise and the full clinical context when making clinical decisions.

Abstract

The complexity of managing inflammatory bowel disease (IBD) stems from the heterogeneity of Crohn’s disease and ulcerative colitis. This leads to differences in disease course, complications, and treatment responses among patients. Current treatment strategies rely on a trial-and-error approach, but there's a need for personalized therapy. Efforts have been made to develop reliable prognostic and predictive biomarkers to overcome disease heterogeneity. This article discusses common mistakes in biomarker development, interpretation, and application in IBD, emphasizing evidence-based insights and lessons learned from other fields.

Topics

IBD

Citation

: Palmer-Jones C. and Lee J. C. Mistakes in biomarkers for IBD and how to avoid them. UEG Education 2023; 23: 8-11.

Published

2023

More Like This:

Mistakes in Pancreatic exocrine insufficiency and how to avoid them

Mistakes in Pancreatic exocrine insufficiency and how to avoid them

Matthias Löhr Matthias Löhr, J. Enrique Domínguez Muñoz, Miroslav Vujasinovic

Malignancy in IBD with Hannah Gordon

Malignancy in IBD with Hannah Gordon

Pradeep Mundre Pradeep Mundre, Hannah Gordon

Mistakes in the management of peritoneal malignancies and how to avoid them

Mistakes in the management of peritoneal malignancies and how to avoid them

Charlotte Rabl Charlotte Rabl, Tarkan Jäger, Andrea Barberis, Matteo Santoliquido, Francesco Saverio Papadia

Transitional care with Patrizia Burra & Jorge Amil Dias

Transitional care with Patrizia Burra & Jorge Amil Dias

Pradeep Mundre Pradeep Mundre, Jorge Amil Dias, Patrizia Burra

Pancreatic cystic neoplasms with Marco del Chiaro

Pancreatic cystic neoplasms with Marco del Chiaro

Egle Dieninyte - Misiune Egle Dieninyte - Misiune, Marco Del Chiaro

Mistakes in biomarkers for IBD and how to avoid them

Mistakes in biomarkers for IBD and how to avoid them

James C. Lee James C. Lee, Chris Palmer-Jones

The global reference point for the digestive health community

Platform Publisher

United European Gastroenterology

Wickenburggasse 1 1080 Vienna, Austria

Contact us

support@ueg.eu

ueg.eu

T: +43 1 997 1639

Legal

Terms & Conditions

Imprint

Privacy Policy

Explore

My Bookmarks

My recommendations

My fields of interest

© 2026 United European Gastroenterology

Change fields of interest

These fields are selected based on the interests in your myUEG profile.
Click the item to unselect it. You can select multiple items.